Pyrazinyl hydroxyacrylamide compounds having an inhibitory effect on the activity of histone deacetylase
US7750155B2 · kind B2 · utility
0Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2007 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Feb 6, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel N-hydroxyacrylamide compounds of formula (I) and pharmaceutically acceptable salts thereof. More particularly, it relates to novel N-hydroxyacrylamide compounds and pharmaceutically acceptable salts thereof which act as a HDAC inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of HDAC-related disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.